RETT SYNDROME STUDY

A Neuren study of trofinetide, also known as NNZ-2566, for females with Rett Syndrome

Eligibility

Who is eligible for this study?

The Rett study is open to a person who:

  • Has a diagnosis of Rett syndrome, with a confirmed MECP2 mutation.
  • Is a female between 5-15 years old.
  • Is able to swallow a liquid medication or take medication through a G-tube.

 

For more information on eligibility criteria for the Rett-002 study, please visit the clinicaltrials.gov web page here.